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Abstract
Background: To examine the correlates of insomnia disorder with different durations in home-dwelling older adults.
Methods: A cross-sectional survey in the Shih-Pai area of Taipei City, Taiwan (The Shih-Pai Sleep Study). A total 4047
subjects over the age of 65 years completed the study (2259 men and 1788 women). The Pittsburgh Sleep
Quality Index and the duration of insomnia symptoms were used to identify DSM-IV 1–6 month and 6-month
insomnia disorders.
Results: The prevalence of DSM-IV defined insomnia disorder was 5.8 %; two-thirds of these case lasted for
≥6 months. The shared correlates for both 1–6 and 6-month insomnia disorders were gender (women), depression
and moderate pain. Pulmonary diseases were exclusively associated with 1–6 month insomnia disorder (OR: 2.57, 95 %
CI: 1.46–4.52). In contrast, heart disease (OR: 1.73, 95 % CI: 1.21–2.49) and severe pain (OR: 2.34, 95 % CI: 1.14–4.40) were
associated with 6-month insomnia disorder.
Conclusion: The prevalence of persistent insomnia disorder is higher than short-term insomnia disorder. Correlates for
less persistent and more persistent insomnia disorder appears to be partially different. Duration quantifiers may
be important in the identification of the etiology of insomnia and further studies with follow-ups are needed to
examine the order of developing insomnia disorder and associated conditions.
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Background
As the architecture of sleep changes along with aging,
sleep becomes vulnerable in older adults [1]. Sleep dis-
turbance is a common public health issue in the elderly.
Although the prevalence of insomnia symptoms is high
in older adults [2–4], insomnia has been more closely
associated with comorbidities rather than with age per
se [2]. Consequences of poor sleep in older adults in-
clude poor health, poor physical function, frequent falls,
cognitive impairment and even mortality [5]. Further-
more, it has been found that a bi-directional association
exists between heart disease, hypertension, chronic pain,
breathing, urinary, gastrointestinal disorders and persist-
ent insomnia [6, 7]. Because persistent insomnia greatly
impairs general health and quality of life [8, 9], it is im-
portant to examine clinical conditions which correlate
with persistence of insomnia in older adults.
During the natural course of insomnia, sleep condition
fluctuates over time. Some insomnia episodes are re-
solved after acute events; some insomnia persists even
when the precipitating factors have been resolved. In the
general population, only 31.6 to 51.5 % of insomnia re-
mits [10, 11], while 44.9 to 66.1 % of insomnia persists
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[11, 12] and the recurrence rate reaches as high as
11.8 % [11]. Because the course of insomnia fluctuates
and persistence between follow-up points is question-
able, it is difficult to evaluate the chronicity of insomnia
in longitudinal studies. With respect to older adults, a 3-
year, large-scale follow-up study reported a remission
rate of insomnia of approximately 50 % in community-
dwelling older adults [13]. Nevertheless, there is less
knowledge about the natural course of insomnia in older
adults. Furthermore, to the best of knowledge, few stud-
ies have used a formal diagnostic system to examine the
persistence of insomnia in older adults [11, 12]. To pre-
vent insomnia from becoming chronic, it is important to
investigate the factors associated with the persistence of
insomnia disorder in older adults [14].
In addition, with regard to the definition of persistent
insomnia, the duration quantifier is not consistent
across various diagnostic systems. According to the
Diagnostic and Statistical Manual of Mental Disorders
4th edition (DSM-IV) diagnostic criteria for primary in-
somnia, insomnia lasting for longer than 1 month is
called persistent insomnia [15]. According to the Inter-
national Classification of Sleep Disorders 2nd edition
(ICSD-2) diagnostic criteria for psychophysiological in-
somnia, insomnia lasting less than 1 month is termed
acute insomnia, whereas insomnia lasting for 1 to
6 months is termed sub-acute insomnia. Insomnia lasting
for more than 6 months is classified as chronic insomnia
[16]. According to the International Classification of
Diseases 10th edition (ICD-10) diagnostic criteria, in-
somnia lasting for longer than 1 month is termed
chronic insomnia [17]. The DSM-V diagnostic criteria
for insomnia disorder define insomnia of longer than
3 months as persistent insomnia [18]. Insomnia dis-
order can be classified as acute or chronic according to
different duration quantifiers, which imply differential
etiologies, associated factors, treatment strategies, and
even outcomes. However, the validity of the duration
quantifiers of insomnia disorder in older adults has not
been examined.
In summary, factors associated with persistence of in-
somnia disorder in older adults warrant further investi-
gation. The present study aims to identify the prevalence
of insomnia disorder in older adults according to differ-
ent duration quantifiers. The second aim was to examine
and compare factors associated with insomnia disorder
specified by different duration quantifiers.
Methods
Study site and participants
This cross-sectional study was part of the Shih-Pai Sleep
Study. The procedure of participant selection has been
detailed elsewhere [19, 20]. In short, the participants
were older adults (aged ≥65) living in the Shih-Pai area
of Taipei City, Taiwan, from 1999 to 2002. In the gov-
ernment household registration system, there were
249,231 people, 65 year-old and older, living in Taipei
City in 1999. According to the same system, 9141 older
people (aged ≥65) lived in this area. In this population,
1990 people lived in institutions, died before they could
be interviewed, moved elsewhere, or could not be con-
tacted. Thus, there were 7151 eligible participants. Data
were collected by well-trained study assistants via door-
to-door, face-to-face interviews after informed consent.
A total of 3104 older adults were unable to be con-
tacted after three attempts or refused to participate;
therefore, 4047 eligible adults completed the interview.
The response rate was 56.6 %. This study was approved
by the institutional review board of the Taipei Veterans
General Hospital.
Demographic data, health behaviors, and medical
conditions
All participants completed a questionnaire that assessed
the socio-demographic characteristics (age, gender,
marital status, educational status, and living status),
health behaviors (including smoking and drinking alco-
hol), and medical diseases (hypertension, diabetes melli-
tus, heart disease, stroke, gouty arthritis, and pulmonary
diseases). In the health behavior, current drinkers were
those who had the habit to drink at least once a week.
Current smoking was defined as people who still had the
habit of smoking during the period of study. Self-report of
pharmacologically-treated chronic diseases was confirmed
by the receipt of relevant medical treatment of the disease
according to their statement during the interview. Infor-
mation about major chronic diseases was collected, in-
cluding diabetes mellitus, hypertension, heart diseases
(such as coronary artery disease, rheumatic heart disease,
etc.), stroke, gouty arthritis and pulmonary diseases (such
as asthma, chronic bronchitis, chronic obstructive pul-
monary disease, etc.).
The Geriatric Depression Scale-Short Form (GDS-SF)
was used to screen for depressive symptoms. The psy-
chometric of Chinese-version of GDS-SF has been
shown to have good validity and reliability [21]. The
suggested cut-off point for the Chinese-version GDS-
SF is 5 and more [22]. Older adults who scored ≥5 on
the GDS-SF were classified as having significant de-
pression. Participants who reported sleepiness at work
or meals during the daytime were classified as having
excessive daytime sleepiness. Pain evaluation is de-
rived from an item on Short Form −36 [23, 24],
which aims to assess the severity of pain in the past
1 month. The original response of pain severity is a
Likert scale, which consists of: (1) no bodily pain, (2)
very mild bodily pain, (3) mild bodily pain, (4) mod-
erate bodily pain, (5) severe bodily pain, (6) very
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severe bodily pain. Because the data is sparse, we
combined the response of “very mild” and “mild” to
“mild”, and “severe” and “very severe” to “severe”. Fi-
nally, severities of pain were classified into 4 scales:
(1) no pain, (2) mild pain, (3) moderate pain, and (4)
severe pain. The number of falls in the past year was
also recorded. A “single fall” indicated having had
only one fall in the past year. If the participants expe-
rienced more than one falling accident, the response
was coded as “repeated falls”.
The diagnosis and classification of insomnia disorder
To identify insomnia disorder, the Chinese version of
Pittsburgh Sleep Quality Index [25, 26] and DSM-IV
criteria for insomnia disorder were used. Chinese ver-
sion of PSQI has been shown to have good validity in
community sample with insomnia disorder [26]. This
approach has been adapted to predict the survival of
older adults with DSM-IV insomnia disorder in an-
other study [20]. The Pittsburgh Sleep Quality Index
is composed of two clusters of questions. The first
cluster assesses nighttime symptoms and the second
cluster assesses sleep quality and daytime dysfunction.
Cluster 1: Nighttime symptoms
1. Difficultly falling asleep: defined as unable to fall
asleep after resting in bed for more than 30 min, or
2. Difficultly maintaining asleep: defined as waking up
more than three times during nighttime sleep, or early
morning awakening: waking up 2 h earlier than usual.
Any symptoms should occur at least three times per
week to qualify for Cluster 1.
Cluster 2: Sleep quality and/or daytime dysfunction
1. Subjectively poor sleep quality (selecting a rating of
3 or 4 on the severity scales) or
2. People who suffered a moderate or greater degree of
daytime dysfunction in emotion, working efficacy,
and daily living (selecting a rating of 3 or 4 on the
severity scales).
If participants met both clusters of symptoms and the
duration was for more than 1 month, they met the diag-
nostic criteria for DSM-IV insomnia disorder. Among
the participants qualified as having insomnia disorder, if
their insomnia persisted for ≥6 months, they were classi-
fied as having a “6-month insomnia disorder.” Partici-
pants who met the diagnosis of insomnia disorder with
the duration of less than 6 months were classified as
having “1–6 month insomnia disorder.”
Statistical analysis
All statistical analyses were conducted using IBM SPSS
Statistics 20 software. Univariate analyses were per-
formed using the chi-square test. Multinomial logistic
regressions with forward stepwise method were used to
examine the correlates of the 1–6 and 6-month insom-
nia disorders. Statistical significance was set as p < 0.05.
Results
Table 1 summarizes the basic characteristics of partici-
pants and the prevalence of insomnia disorders. Of the
participants, 37.6 % were ≥75 years and 55.8 % were
male. There was no significant difference between the
study subjects and registered data on people older than
65 year-old in Taipei with respect to age (χ2 = 1.02,
df = 1, P = 0.31) and gender (χ2 = 1.91, df = 1, P = 0.17).
Overall, the prevalence of DSM-IV insomnia disorder
was 5.8 %; 67.2 % of individuals with identified in-
somnia disorders had the 6-month insomnia disorder.
Specifically, out of all participants, the prevalence of 1–6
month insomnia disorder and 6-month insomnia disorder
was 1.9 and 3.9 %, respectively. Women (p < 0.001) and
single individuals (p = 0.005) had a higher prevalence of
DSM-IV insomnia disorder. Women had a higher preva-
lence of insomnia disorder for both duration quantifiers
(1–6 month: 2.7 % of women vs. 1.3 % of men; and
6 months: 5.0 % of women vs. 3.0 % of men). Similarly,
compared with married participants, single older adults
had a higher prevalence of insomnia disorder for both
duration quantifiers (1–6 month: 3.0 % of single individ-
uals vs. 1.6 % of married individuals; 6 months: 4.6 % of
single individuals vs. 3.6 % of married individuals).
Table 2 shows the distribution of common medical
conditions and their respective prevalence of insomnia
disorders. Of the participants, 71.2 % had at least one
of the 13 identified medical conditions. Insomnia disorder
was significantly associated with heart disease (p < 0.001),
stroke (p = 0.002), pulmonary diseases (p = 0.001), depres-
sion (p < 0.001), excessive daytime sleepiness (p = 0.01),
pain (p < 0.001), and falling (p = 0.001). The prevalence of
insomnia disorders by common medical conditions
ranged from 6.2 to 18.0 %. However, in participants with-
out any medical conditions, the prevalence of a DSM-IV
insomnia disorder was only 2.4 %. Figure 1 illustrates the
prevalence rates across various medical conditions. Older
adults with depression had the highest prevalence of in-
somnia disorder (18.0 %), followed by those reporting
moderate pain (14.6 %), and severe pain (14.5 %).
Figure 2 depicts the distribution of insomnia disorder
with different duration quantifiers across various med-
ical conditions. The 6-month insomnia disorder was
most common among older adults with severe pain
(86.9 %) followed by those with stroke (78.0 %), heart
disease (76.2 %), depression (76.1 %), gouty arthritis
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(76.1 %) and repeated falls (73.2 %). In comparison, the
1–6 month insomnia disorder was most common among
older adults who had pulmonary diseases (39.0 %),
followed by those with moderate pain (35.6 %), single fall
(35.5 %) and excessive daytime sleepiness (35.2 %). In
this study, the validity of a chronic disease was con-
firmed by both self-report diagnosis and concurrent
medication use (pharmacologically-treated). Because
some patients with chronic diseases may receive non-
pharmacological intervention, our approach for the con-
firmation of diagnosis may bias the relationship between
chronic diseases and insomnia disorders with different
durations. Therefore, the distribution of treatment pat-
terns among different durations of insomnia disorders
were further examined with chi-squared tests. The re-
sults revealed no significant differences with respect to
all chronic diseases.
Table 3 shows the results of multivariate analyses
for factors associated with 1–6 and 6-month insomnia
disorder. The multinomial stepwise logistic regression
showed that 1–6 month insomnia disorder was associated
with being a woman (OR: 2.16, 95 % CI:1.33–3.51), having
pulmonary diseases (OR: 2.57, 95 % CI: 1.46–4.52), having
depression (OR: 2.81, 95 % CI: 1.59–4.96) and moderate
pain (OR:2.56, 95 % CI:1.23–5.32). In contrast, 6-month
insomnia disorder was associated with being a woman
(OR: 1.50, 95 % CI: 1.07–2.10) and having heart disease
(OR: 1.73, 95 % CI: 1.21–2.49), depression (OR: 4.68, 95 %
CI: 3.24–6.75), or moderate and severe pain (OR: 2.23,
95 % CI: 1.26–3.93 and OR: 2.34, 95 % CI:1.14–4.40)
respectively.
Discussion
The present study reported the prevalence of DSM-IV
defined insomnia disorder and its correlates for different
duration quantifiers. The prevalence of DSM-IV insom-
nia disorder was 5.8 % among home-dwelling older
adults, and the insomnia lasted for more than 6 months
for two-thirds of this group. However, in healthy partici-
pants, the prevalence was only 2.4 %. Although a higher
Table 1 Demographics and health behavior of participants by different durations of DSM-IV insomnia disorder (n = 4047)a
Insomnia status
Total No insomnia 1–6 month insomnia disorder 6-month insomnia disorder p-value for X2
n = 4047 n = 3794 n = 78 n = 160
n (%) n Rate (%) n Rate (%) n Rate (%)
Demographic data
Age (years)
≥75 1523 37.6 2371 94.4 46 1.8 94 3.7 0.65
<75 2524 62.4 1421 93.7 32 2.1 63 4.2
Gender
Male 2259 55.8 2150 95.6 30 1.3 68 3.0 <0.001
Female 1788 44.2 1643 92.3 8 2.7 89 5.0
Education
Illiterate 677 16.7 3162 94.2 63 1.9 131 3.9 0.83
Literate 3370 83.3 632 93.9 15 2.2 26 3.9
Marital status
Married 3008 74.3 2838 94.8 47 1.6 109 3.6 0.005
Single, divorced and widowed 1039 25.7 956 92.4 31 3.0 48 4.6
Living status
With others 3818 94.3 3583 94.3 74 1.9 144 3.8 0.35
Alone 229 5.7 211 92.5 4 1.8 13 5.7
Health behavior
Smoking
Not current smoker 3354 82.9 3139 94 67 2.0 135 4.0 0.44
Current smoker 693 17.1 655 95.2 11 1.6 22 3.2
Alcohol
Not current drinker 3675 90.9 3442 94.1 71 1.9 145 4.0 0.78
Current drinker 372 9.2 352 94.9 7 1.9 12 3.2
aDue to missing data, total numbers of participants in some variables are different
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Table 2 Prevalence of DSM-IV insomnia disorder with different durations in various medical conditions (n = 4047)a
Insomnia status
Total No insomnia 1–6 month insomnia disorder 6-month insomnia disorder p-value for X2
n = 4047 n = 3794 n = 78 n = 160
n (%) n Rate (%) n Rate (%) n Rate (%)
Medical conditions
No medical conditions 1161 28.8 1133 97.6 9 0.8 19 1.6 <0.001
Any medical conditions 2868 71.2 2661 92.8 69 2.4 138 4.8
Chronic diseasesb
Diabetes mellitus
No diabetes mellitus 3523 87.1 3304 94.3 67 1.9 134 3.8 0.78
Diabetes mellitus 524 12.9 490 93.5 11 2.1 23 4.4
Hypertension
No hypertension 2467 61.0 2323 94.5 44 1.8 91 3.7 0.50
Hypertension 1580 39.0 1471 93.6 34 2.2 66 4.2
Heart disease
No heart disease 3258 80.5 3074 94.8 62 1.9 107 3.3 <0.001
Heart disease 789 19.5 720 91.6 16 2.0 50 6.4
Stroke
No stroke 3895 96.2 3660 94.4 74 1.9 143 3.7 0.002
Stroke 152 3.8 134 88.2 4 2.6 14 9.2
Gouty arthritis
No gouty arthritis 3735 92.3 3505 94.2 72 1.9 142 3.8 0.67
Gouty arthritis 312 7.7 289 93.2 6 1.9 15 4.8
Pulmonary diseases
No pulmonary diseases 3584 88.6 3375 94.6 61 1.7 130 3.6 0.001
Pulmonary diseases 463 9.8 419 90.5 17 3.7 27 5.8
Depression
Geriatric depression scale <5 3612 89.3 3437 95.5 60 1.7 102 2.8 <0.001
Geriatric depression scale≥5 396 9.8 324 82.0 17 4.3 54 13.7
Clinical conditions
Excessive daytime sleepiness
No 3602 89.0 3395 94.6 64 1.8 131 3.6 0.01
Yes 445 11.0 399 90.9 14 3.2 26 5.9
Pain
No 2660 66.2 2534 95.3 45 1.7 81 3.0 <0.001
Mild 1070 26.6 1004 93.8 21 2.0 45 4.2
Moderate 191 4.7 163 85.3 10 5.2 18 9.4
Severe 103 2.6 88 85.4 2 1.9 13 12.6
Fall
No fall 3491 86.3 3294 94.8 59 1.7 121 3.5 0.001
Single fall 398 9.8 361 90.7 13 3.3 24 6.0
Repeated falls 134 3.3 119 88.8 4 3.0 11 8.2
aDue to missing data, total numbers of participants in some variables are different
bChronic diseases were defined as pharmacologically-treated morbidities
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proportion of DSM-IV insomnia disorder tended to
last for ≥6 months, factors associated with the 1–6
and 6-month insomnia disorders differed. Gender
(women), depression and moderate bodily pain were
shared correlates for both 1–6 and 6-month insomnia
disorders. Pulmonary diseases were exclusively related
to 1–6 month insomnia disorder. In contrast, heart
disease and severe pain were exclusively associated
with 6-month insomnia disorder. These findings support
the importance of examining the validity of duration
quantifiers for insomnia disorders. To the best of our
knowledge, this is the first study to explore the correlates
of insomnia disorder with different chronicities in older
adults.
The prevalence of insomnia in older adults varies in
the definition of insomnia. A systemic review noted
that the prevalence of insomnia symptoms in older
adults was 6.9–48.0 %, insomnia symptoms plus day-
time symptoms was 9–15 %, poor sleep quality and
quantity was 8–18 %, and DSM-IV insomnia criteria
Fig. 1 Prevalence of DSM-IV insomnia disorder in various medical conditions. (Chronic diseases were defined as pharmacologically-treated
morbidities.)
Fig. 2 The distribution of DSM-IV insomnia disorder with different duration quantifiers in various medical conditions. (Chronic diseases
were defined as pharmacologically-treated morbidities.)
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was only 4.4–6.4 % [27]. In contrast, in older adults
in the Chinese population, the prevalence of insomnia
symptoms was about 14.0 to 39.2 % [4, 28, 29] and
that of poor sleep quality ranged from 16.0 to 49.7 %
[30–35]. In the present study, the prevalence of
DSM-IV insomnia disorder was 5.8 %. As far as we
know, the prevalence of DSM-IV insomnia disorder
has never been surveyed in the Chinese population,
except the Shih-Pai cohort [19, 20]. In general, the
prevalence of insomnia of various definitions in older
Chinese adults was comparable with the worldwide preva-
lence, including DSM-IV insomnia disorder [27, 36, 37].
Although the effect of the year or cohort may influence
the findings of epidemiological studies, the prevalence of
insomnia appears to vary more greatly with the definition
of insomnia rather than the effect of the year or the cohort
[27]. However, large-scale epidemiologic studies for a
more recent Chinese cohort of older adults are still neces-
sary to update the information about prevalence and cor-
relates of insomnia disorders with different chronicity.
Insomnia has been observed to have a chronic course
and insomnia disorder is more likely to persist than are
mere insomnia symptoms. A 1-year follow-up study in
Sweden showed that the persistence rate of insomnia
was 44.4 % in the general population [11, 12]. Another
follow-up study in the United States found persistence
rates for insomnia symptoms and diagnosed insomnia in
the general population were 37.2 and 66.6 %, respect-
ively [11]. In community-dwelling older adults, only
50 % experienced remission of insomnia symptoms over
the 3-year follow-up period [13]. In the present study,
because of the cross-sectional design, we could not
evaluate the persistence rate of insomnia disorder. How-
ever, the high proportion of insomnia disorder with a
duration of ≥6 months is a reflection of the persistent
nature of insomnia disorder. Further longitudinal studies
are necessary to determine the pattern of the course,
and associated factors of the chronicity of insomnia dis-
order in older adults.
Although the cohort for the present study was estab-
lished during 1999 to 2002, correlates identified for in-
somnia disorder are similar to those otherwise reported
in recent studies [29, 30, 34, 38]. In the regression ana-
lyses, gender, physical diseases, depression, and pain
stood out as significant correlates of DSM-IV insomnia
disorders. In the literature, women, depression, use of
hypnotics, respiratory symptoms, poor self-rated health,
and somatic symptoms have been reported to correlate
with insomnia symptoms in older adults [3, 28]. In con-
trast, only a few studies have focused on examining the
associated factors of insomnia disorder. Furthermore, no
studies have compared the factors associated with dur-
ation of insomnia disorders.
Being female has been widely identified as a risk indi-
cator across the life span for insomnia, including among
older adults. However, it has been argued that the asso-
ciation between being female and insomnia symptoms in
older adults is confounded by depression, chronic dis-
eases, living alone, marital status, occupational status,
and social support deficits [39]. Nevertheless, in the
present study, even after adjusting for various covariates,
being female remained a significant correlate for both
1–6 and 6-month insomnia disorders. Therefore, in
older adults, being female should be seen as consistent
risk indicator for insomnia, at least for DSM-IV insom-
nia disorder.
In the literature, the association between insomnia and
depression has been widely examined [3, 28, 40–43] and
a bidirectional relationship between insomnia and de-
pression is also well-known [44]. In parallel, insomnia
also predicts the development and recurrence of depres-
sion in older adults [42]. Furthermore, persistent sleep
disturbance, instead of intermittent sleep disturbance,
predicted the recurrence of depression in older adults
[41]. On the contrary, although there is no specific re-
search reporting the residual insomnia symptoms in
older adults, it has been reported that high proportion
Table 3 Multinomial logistic regression analysis with forward






OR (95 % CI) OR (95 % CI)
Gender
Male 1 1
Female 2.16 (1.33–3.51) 1.50 (1.07–2.10)
Heart disease
No heart disease 1 1
Heart disease 0.92 (0.51–1.65) 1.73 (1.21–2.49)
Pulmonary disease
No pulmonary disease 1 1







2.81 (1.59–4.96) 4.68 (3.24–6.75)
Pain
No 1 1
Mild 1.01 (0.59–1.73) 1.08 (0.74–1.59)
Moderate 2.56 (1.23–5.32) 2.23 (1.26–3.93)
Severe 0.39 (0.05–2.93) 2.34 (1.14–4.40)
Covariates entered the model were age, gender, educational status, marital
status, living status, smoking, alcohol use, diabetes mellitus, hypertension,
heart disease, stroke, gouty arthritis, pulmonary diseases, depression, excessive
daytime sleepiness, different severities of pain, falls
Chiou et al. BMC Geriatrics  (2016) 16:119 Page 7 of 11
of depressive patients have severe insomnia, and insom-
nia symptoms tend to persist even after the remission of
depression [45]. In the present study, although depres-
sion was associated with both the 1–6 and 6-month in-
somnia disorders, the magnitude of the association was
greater for the 6-month insomnia disorder. Because of
the cross-sectional design of the present study, it is im-
possible to infer the temporal relationship between
DSM-IV insomnia disorder and depression. However,
the relationship between depression and insomnia dis-
order seemed to amplify over time. This finding implied
that chronic and severe insomnia in older adults particu-
larly signals the risk of co-occurrence of depression.
Insomnia and pain are also mutually influenced.
Pain increases the risk of incident and persistent in-
somnia [46–48], and sleep disturbance can perpetuate
pain [46, 49, 50]. Severe pain in patients with diabetic
peripheral neuropathy has been shown to correlate
with sleep problems [51]. Furthermore, the impact of
sleep on pain accumulates over time; therefore, in-
creased severe pain may be more closely related to
persistent insomnia [49]. In the present study, moderate
pain was associated with both 1–6 month insomnia dis-
order and 6-month insomnia disorder; whereas, severe
pain was exclusively associated with 6-month insomnia
disorder. This finding supported the previous observation
that pain influences persistent insomnia and the im-
pact of sleep on pain accumulated over time. Several
clinical conditions, including osteoporosis, rheumatoid
arthritis, arthrosis, Bechterew’s disease, migraine, and
musculoskeletal disorders, were found to cause pain
and subsequently result in insomnia in the older
adults [52]. In addition, pain sites may also determine
the pattern of sleep disturbance. For example, back
pain may result in non-refreshing sleep, morning
headache may indicate an underlying sleep-disordered
breathing, and migraine may hint sleep deprivation
[53]. However, there is no study examining the associ-
ation between underlying causes and specific sites of
pain with the persistence of insomnia disorder. In the
future, studies that aim to disentangle the relationship
between causes and sites of pain and persistence of
insomnia disorder are necessary. At least, according
to a previous report and our finding, it suggests that
pain in older adults with DSM-IV insomnia disorders
warrants in-depth survey of the underlying medical
causes and specific sites of pain.
Chronic diseases correlate closely with various sleep
disturbances in older adults [7, 43]. In the present study,
the prevalence of insomnia disorder in healthy partici-
pants was not only lower than in older adults with med-
ical conditions, but was also lower than the prevalence
reported in the general population [27]. Because both
aging and chronic diseases compromise older adults’
ability to sleep, it is imperative to elucidate the link be-
tween sleep disturbance and medical comorbidities. In
2003, the “Sleep in America Survey” found that different
sleep disturbances might correlate with different cat-
egories of self-reported physical conditions. In the “Sleep
in America Survey”, depression and heart disease were
associated with more general insomnia symptoms. In
contrast, pulmonary diseases, obesity, diabetes mellitus,
arthritis, stroke, and osteoporosis were associated with
other sleep disturbances, such as sleep breathing disorder,
snoring, and excessive daytime sleepiness [43]. This find-
ing implied that different chronic diseases might interact
with and affect sleep through different pathways. In fact,
the clinical course of many physical diseases is chronic in
nature. However, according to the features of individual
diseases and their treatment modalities, they may influ-
ence sleep in either an acute or a chronic pattern.
In the present study, pulmonary diseases were found
to be associated with the less persistent, 1–6 month in-
somnia disorder. On the other hand, heart disease was
found to be associated with the more persistent, 6-
month insomnia disorder. There are some potential ex-
planations for the differential pattern of comorbidities of
1–6 month and 6-month insomnia disorders. Firstly,
many pulmonary diseases influence sleep, such as
chronic obstructive pulmonary disease, asthma, and ob-
structive sleep apnea [54, 55]. Pulmonary diseases and
sleep have a bidirectional relationship [56]. When noc-
turnal symptoms of pulmonary diseases are aggravated,
the patients’ sleep quality worsens [57, 58]. In the other
direction, sleep disturbance predicted the acute exacer-
bation of pulmonary diseases and the need for pertinent
emergency services [59]. The episodic attacks that
characterize many pulmonary diseases may contribute to
the link with episodic short-term sleep disturbance.
Symptoms of pulmonary diseases such as asthma or
chronic obstructive pulmonary disease would aggravate
during acute infection or exacerbation [60]. In the mul-
tiple logistic regression, pulmonary diseases were only
associated with the 1–6 month insomnia disorder, but
not with the 6-month insomnia disorder. This finding
echoes the above argument about the link between epi-
sodic attacks and short-term sleep disturbance.
In contrast, heart disease was exclusively related to
6-month insomnia disorder in the present study. The
evidence that insomnia contributes to heart disease is
robust [61–64]. Insomnia has been found to increases
the risk of incidents of coronary heart disease and
elevated cardiovascular mortality. As a result, sleep
disturbances are regarded as one of the top ten
potentially modifiable risk factors for cardiovascular
disease [65]. Insomnia may affect cardiovascular sys-
tem by having a negative impact on metabolism,
endocrine, autonomic nervous system, hemodynamic,
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cardiac, endothelial, and platelet aggregation functions
[66, 67]. Furthermore, insomnia may share some
common risk factors with heart disease [62]. This
finding may suggest that chronic insomnia seems to
be more likely comorbid with diseases in the cardio-
vascular system.
Although the pattern of correlates for insomnia dis-
order with different duration of chronicity appears to
differ with regard to amount and essence, the interpret-
ation about the differential pattern requires caution.
Firstly, the case number of 1–6 month insomnia dis-
order (n = 78) and 6-month insomnia disorder (n = 160)
were different. The case number of 1–6 month insomnia
disorder was around half that of 6-month insomnia dis-
order. Therefore, the differential pattern between the in-
somnia disorders with different durations may just
reflect the disparity in statistical power. Some potential
correlates for 1–6 month insomnia may be underpow-
ered as they failed to turn out statistically significant.
Secondly, some patients classified as 1–6 month insom-
nia disorder might develop 6-month insomnia disorder
later. This misclassification was caused by the limitation
of diagnostic criteria. This systemic bias will introduce
misclassification bias and should be non-differential in
essence. Therefore, it would result in a bias toward the
null. According to these methodological considerations
for the present studies, correlates that specifically ap-
peared as correlates for 1–6 month insomnia disorder,
such as pulmonary diseases, are rather robust in evi-
dence, because of both under-power and the bias which
is toward the null. In contrast, correlates identified spe-
cifically for 6-months insomnia disorder may be errone-
ous accordingly, such as heart disease and severe pain.
Thirdly, our findings merely suggest correlates for older
adults with 1–6 month and 6-month insomnia disorder,
respectively. Our findings did not suggest predictors to
develop 6-month insomnia disorder among individuals
with DSM-IV insomnia disorder.
Limitations
There were several limitations in this study. First, study
subjects were home-dwelling older adults who lived in
an urban area. Older adults who reside in rural areas
and those who have been institutionalized were not in-
cluded. A previous study found that associated factors
differed among older adults living in rural and urban
areas [29]. Thus, the study results could only be general-
ized to home-dwelling older adults living in an urban
area. Second, this study was a cross-sectional investiga-
tion, which prevents any inference of causal relations be-
tween the 1–6 month and 6-month insomnia disorders
and their associated factors. Third, according to the
study aims and the consideration of statistical power of
the present study, only common correlates for insomnia
disorder were included into the analyses. However, there
remain some important medical diseases, such as genito-
urinary disease, and cancer, which may correlate with
specific durations of insomnia disorders and should be
considered in the analyses. It is not possible to reveal
whether differential correlation exists between uncol-
lected data on these medical diseases and specific dura-
tions of insomnia disorders. Therefore, we could not
generalize the results to older adults with these uncol-
lected medical conditions. Furthermore, if these medical
diseases correlate with insomnia disorder and distribute
unequally in the current recruited variables, the present
findings may be further confounded. Therefore, a large-
scale prospective study with detailed survey of chronic
diseases is necessary to provide a more comprehensive
understanding of the relationship between chronic dis-
eases and insomnia disorder. Fourth, in the older adults,
exercise can improve sleep quality [68]. On the contrary,
physical disability is associated with poor sleep quality
[69]. Unfortunately, items related to exercise were not
included in our questionnaire. Therefore, we could not
analyze the influence of physical activity on insomnia.
Fifthly, many commonly used medications, which also
impact sleep were not included in the analyses. Al-
though, some confounding effects of these medications
may be under-controlled, simultaneous inclusion of
chronic diseases and their respective medications may
result in over-control. Besides, discarding chronic dis-
eases and only including their medications into the stat-
istical models may also lead to the confounding by
disease indication [70]. Therefore, an ingenious statis-
tical or methodological approach to disentangle the
complex relationship among chronic diseases, medica-
tions, and insomnia disorders should be considered in
the future work. Finally, the accuracy of the self-
reported duration of insomnia warrants discussion. Al-
though retrospective recall is an inherent feature of sleep
studies, the decline of cognitive function in older adults
may further bias the subjective reporting of the duration
of insomnia. In the present study, cognitive function test
for each participant was not available. However, eligible
participants, who were able to complete the entire
process of data collection for the present study, satisfied
cognitive criteria for a near 40-min interview. Therefore,
the bias brought by cognitive decline during normal
aging might be minimal. In addition, individuals with in-
somnia have been shown to underestimate their sleep ef-
ficacy [71–74]. In the future, it is of interest to examine
how cognitive decline and subjective bias of older in-
somniacs influence the reporting of insomnia duration.
Conclusion
In home-dwelling older adults, the prevalence of persist-
ent insomnia disorder was higher than short-term
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insomnia disorder. Correlates for less persistent and
more persistent insomnia disorder appeared to be dif-
ferent. Our findings suggested that duration quanti-
fiers may be important in the identification of the
etiology of insomnia. Because the complex relation-
ship between insomnia disorder and its correlates,
clear clinical recommendations are possible only after
the temporal relationship between the development of
insomnia disorder and the associated conditions are
examined by further follow-up studies in the future.
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